Malcolm L. Meeson

CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound

Ian T. Forbes, David G. Cooper, Emma K. Dodds et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 53 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-Substituted-4-(phenylamino)quinolines

Robert J. Ife, Thomas H. Brown, David J. Keeling et al. · Journal of Medicinal Chemistry · 1992 · 53 citations · Full text

Medicine, Biochemistry, Pharmacology +10

Reversible Inhibitors of the Gastric (H+/K+)-ATPase. 5. Substituted 2,4-Diaminoquinazolines and Thienopyrimidines

Robert J. Ife, Thomas H. Brown, Peter Blurton et al. · Journal of Medicinal Chemistry · 1995 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

2-[[(4-Amino-2-pyridyl)methyl]sulfinyl]benzimidazole H+/K+-ATPase inhibitors. The relationship between pyridine basicity, stability, and activity

Robert J. Ife, Catherine A. Dyke, David J. Keeling et al. · Journal of Medicinal Chemistry · 1989 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Identification of a novel series of selective 5-HT7 receptor antagonists

Ian T. Forbes, David G. Cooper, Emma K. Dodds et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14